Copyright: © 2026 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

The original peptide complex affects the prostate tissue oxygen consumption rate in rats

Lobkarev AO1,2 , Muzhekhoev AA3 , Evloev MK3 , Dzhandigov RB4 , Korigov IA4
About authors

1 Kazan State Medical University, Kazan, Russia

2 Mother and Child Clinic, Kazan, Russia

3 Bekbotov Nazran Central District Hospital, Magas, Russia

4 Republican Center for Disaster Medicine and Emergency Care, Magas, Russia

Correspondence should be addressed: Alexey O. Lobkarev
Daurskaya 34А, Kazan, 420087, Russia; ur.liam@verakboloa

About paper

Author contribution: Lobkarev AO — concept, research procedure, material processing, manuscript editing; Muzhekhoev AA, Dzhandigov RB, Evloev MK, Korigov IA — literature review, statistical processing, manuscript writing.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Kazan State Medical Academy (protocol No. 3/05 dated 06 May 2015). Animals were kept and handled in accordance with the requirements of the Declaration of Helsinki.

Received: 2026-05-19 Accepted: 2026-06-10 Published online: 2026-06-21
|
  1. Strategiya dejstvij po realizacii semejnoj i demograficheskoj politiki, podderzhke mnogodetnosti v Rossijskoj Federacii do 2036 goda. Utverzhdena Rasporyazheniem Pravitel'stva Rossijskoj Federacii № 615-r 15 marta 2025 g. M., 2025, 46 s. Russian.
  2. Sivkov AV, Romih VV, Zaharchenko AV. Hronicheskij prostatit kategorii IIIV / sindrom hronicheskoj tazovoj boli i seksual'nye disfunkcii. Andrologiya i genital'naya hirurgiya. 2015; 16 (4): 18– 26. Russian.
  3. Aboyan IA, Tolmachev AN, Lemeshko SI. Morfologicheskaya harakteristika tkani giperplazirovannoj predstatel'noj zhelezy pri hronicheskom prostatite. Eksperimental'naya i klinicheskaya urologiya. 2020; (4): 82–88. Dostupno po ssylke: https://doi.org/10.29188/2222-8543-2020-13-4-82-88. Russian.
  4. Taitt HE. Global trends and prostate cancer: a review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location. American Journal of Men’s Health. 2018; 12 (6): 1807–23. DOI: 10.1177/1557988318798279.
  5. Negoita S, Feuer EJ, Mariotto A, Cronin KA, Petkov VI, Hussey SK, et al. Annual report to the nation on the status of cancer, part II: Recent changes in prostate cancer trends and disease characteristics. Cancer. 2018; 124 (13): 2801–14. DOI: 10.1002/cncr.31549.
  6. Instrukciya po primeneniyu Vitual Kompleks Peptidov POLO 3 Plyus № 60, kapsuly massoj 0,2 g. Sankt-Peterburg, 2026; 2 s. Russian.
  7. Davidson A. Oxford Companion to Food. 3rd ed. Oxford University Press, 2014; 921 p.
  8. Glanc S. Mediko-biologicheskaya statistika. M.: Praktika, 1999; 459 s.
  9. Opticheskij datchik rastvorennogo kisloroda s termoelektricheskim preobrazovatelem DKTP-03. Pasport i rukovodstvo po ekspluatacii. M., 2015; 12 s. Russian.
  10. Analizator rastvorennogo kisloroda «Ekspert-009». Rukovodstvo po ekspluatacii i metodika poverki. M., 2019; 46 s. Russian.
  11. Sergeev PV, Shimanovskij NL, redaktory. Biohimicheskaya farmakologiya: uchebnoe posobie. M.: MIA, 2010; 624 s. Russian.
  12. Wang Y, Bao Y, Liu J. Tadalafil 5 mg once daily improves lower urinary tract symptoms and erectile dysfunction: a systematic review and meta-analysis. Lower Urinary Tract Symptoms. 2018; 10 (1): 84–92.
  13. Balhara YP, Sarkar S, Gupta R. Phosphodiesterase-5 inhibitors for erectile dysfunction in patients with diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Indian Journal of Endocrinology and Metabolism. 2015; 4: 451–61.
  14. Lobkarev AO. Tadalafil raises the rate of oxygen consumption by the cells of prostate. Medicus. 2017; 3: 93–98.
  15. Lobkarev A, Khafizyanova R, Lobkarev O, Borovskaya T, Vychuzhanina A, Grigoreva V, et al. Comparative study of the influence of tadalafil and doxazosin on the rate of oxygen consumption by prostate tissue in Sprague-Dawley rats and in white outbred rats. Possible clinical consequences of unstudied pharmacological effect in men with lower urinary tract symptoms. Pharmacology Online. 2020; 1: 144–9. DOI: 10.18411/phol-2020-1-144-149.
  16. Barcroft J. The respiratory function of the blood. Cambridge: Cambridge University Press, 1914; 320 p.
  17. Krogh A. The respiratory exchange of animals and man. London: Longmans, Green and Co, 1916; 173 p.
  18. Krogh A. The anatomy and physiology of capillaries. New Heaven: Yale University Press, 1922; 276 p.
  19. Ryabov GA. Gipoksiya kriticheskih sostoyanij. M.: Medicina, 1988; 288 s. Russian.
  20. Skulachev VP, Bogachev AV, Kasparinskij FO. Membrannaya bioenergetika. M.: Izdatel'stvo Moskovskogo universiteta, 2012; 368 s. Russian.
  21. Havinson VH, Trofimova SM. Sekrety dolgoj zhizni. M.: Eksmo, 2020; 184 s. Russian.
  22. Kuzmin IV, SHabudina NO, Al-SHukri SH. Peptidy predstatel'noj zhelezy v lechenii bol'nyh s simptomami nizhnih mochevyh putej vsledstvie dobrokachestvennoj giperplazii predstatel'noj zhelezy. Effektivnaya farmakoterapiya. 2015; 18 (2): 16–22. Russian.
  23. Tkachuk VN, Tkachuk IN, Borovec SYu. Rezul'taty 12-letnego issledovaniya effektivnosti vitaprosta u bol'nyh hronicheskim prostatitom. Urologicheskie vedomosti. 2016; 6 (4): 5–9. DOI: 10.17816/uroved645-9. Russian.
  24. Uchvatkin GV, Tatarinceva MB. Prostaticheskie peptidy v lechenii zabolevanij predstatel'noj zhelezy. Urologicheskie vedomosti. 2017; 7 (3): 44–48. DOI: 10.17816/uroved7344-48. Russian.